NEW YORK, Sept. 4 /Xinhua-PRNewswire-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE: AOB), a pharmaceutical company dedicated to
improving health through the development, manufacture and commercialization
of a broad range of prescription and over the counter ("OTC") products in
China, today announced that the Company will present at the following
1. Morgan Stanley Global Healthcare Unplugged Conference, held at the
Grand Hyatt in New York on September 9, 2008;
2. Merrill Lynch Global Pharmaceutical Conference, held at the Merrill
Lynch Financial Centre in London on September 17, 2008;
3. UBS Global Life Sciences Conference, held at the Grand Hyatt in New
York on September 25, 2008. To access the webcast of this event,
please go to http://www.ibb.ubs.com/ .
Management will also hold one-on-one meetings at the conferences. For more details on the aforementioned conferences, please visit the respective conference organizers websites.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.
Statements made in this press release are forward-looking and are made
pursuant to the safe harbor provisions of the Securities Litigation Reform
Act of 1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these
statements. The economic, competitive, governmental, technological and
other factors identified in t
|SOURCE American Oriental Bioengineering, Inc.|
Copyright©2008 PR Newswire.
All rights reserved